| Literature DB >> 32428502 |
Bart Tummers1, Luigi Mari1, Clifford S Guy1, Bradlee L Heckmann1, Diego A Rodriguez1, Sebastian Rühl1, Julien Moretti2, Jeremy Chase Crawford1, Patrick Fitzgerald1, Thirumala-Devi Kanneganti1, Laura J Janke3, Stephane Pelletier1, J Magarian Blander4, Douglas R Green5.
Abstract
Cell death pathways regulate various homeostatic processes. Autoimmune lymphoproliferative syndrome (ALPS) in humans and lymphoproliferative (LPR) disease in mice result from abrogated CD95-induced apoptosis. Because caspase-8 mediates CD95 signaling, we applied genetic approaches to dissect the roles of caspase-8 in cell death and inflammation. Here, we describe oligomerization-deficient Caspase-8F122GL123G/F122GL123G and non-cleavable Caspase-8D387A/D387A mutant mice with defective caspase-8-mediated apoptosis. Although neither mouse developed LPR disease, removal of the necroptosis effector Mlkl from Caspase-8D387A/D387A mice revealed an inflammatory role of caspase-8. Ablation of one allele of Fasl, Fadd, or Ripk1 prevented the pathology of Casp8D387A/D387AMlkl-/- animals. Removing both Fadd alleles from these mice resulted in early lethality prior to post-natal day 15 (P15), which was prevented by co-ablation of either Ripk1 or Caspase-1. Our results suggest an in vivo role of the inflammatory RIPK1-caspase-8-FADD (FADDosome) complex and reveal a FADD-independent inflammatory role of caspase-8 that involves activation of an inflammasome.Entities:
Keywords: FADD; Inflammasome; apoptosis; autoimmune lymphoproliferative syndrome; caspase; inflammation; necroptosis; pyroptosis
Mesh:
Substances:
Year: 2020 PMID: 32428502 PMCID: PMC7306001 DOI: 10.1016/j.immuni.2020.04.010
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745